These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23314606)

  • 1. CD24 polymorphisms in breast cancer: impact on prognosis and risk.
    Buck K; Hug S; Seibold P; Ferschke I; Altevogt P; Sohn C; Schneeweiss A; Burwinkel B; Jäger D; Flesch-Janys D; Chang-Claude J; Marmé F
    Breast Cancer Res Treat; 2013 Feb; 137(3):927-37. PubMed ID: 23314606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD24 polymorphisms cannot predict pathologic complete response to anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer.
    Zhou X
    Clin Breast Cancer; 2014 Apr; 14(2):e33-40. PubMed ID: 24393851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.
    Marmé F; Werft W; Walter A; Keller S; Wang X; Benner A; Burwinkel B; Sinn P; Hug S; Sohn C; Bretz N; Moldenhauer G; Rupp C; Rupp AK; Biakhov MY; Bottini A; Friedrichs K; Khailenko VA; Manikhas GM; Ruiz A; Sánchez-Rovira P; Santoro A; Segui MA; Villena C; Lichter P; Kristiansen G; Altevogt P; Schneeweiss A
    Breast Cancer Res Treat; 2012 Apr; 132(3):819-31. PubMed ID: 21960110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis.
    Rueda B; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2008 May; 35(5):850-4. PubMed ID: 18381780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis.
    Ishitobi M; Miyoshi Y; Ando A; Hasegawa S; Egawa C; Tamaki Y; Monden M; Noguchi S
    Clin Cancer Res; 2003 Apr; 9(4):1376-80. PubMed ID: 12684407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
    Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD24 Ala57Val gene polymorphism and the risk of systemic lupus erythematosus.
    Piotrowski P; Lianeri M; Wudarski M; Łacki JK; Jagodziński PP
    Tissue Antigens; 2010 Jun; 75(6):696-700. PubMed ID: 20230526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
    DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
    Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R; Yip CH; Taib NA
    Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
    Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
    Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.
    Zúbor P; Vojvodová A; Danko J; Kajo K; Szunyogh N; Lasabová Z; Biringer K; Visnovský J; Dókus K; Galajda P; Plank L
    Neoplasma; 2006; 53(1):49-55. PubMed ID: 16416013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic polymorphisms in the VEGF gene with breast cancer survival.
    Lu H; Shu XO; Cui Y; Kataoka N; Wen W; Cai Q; Ruan ZX; Gao YT; Zheng W
    Cancer Res; 2005 Jun; 65(12):5015-9. PubMed ID: 15958542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
    Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
    Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
    Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
    Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study.
    Lilla C; Risch A; Kropp S; Chang-Claude J
    Breast Cancer Res; 2005; 7(2):R229-37. PubMed ID: 15743503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.